Healthcare Bioconvergence Market
According to Intent Market Research, the Healthcare Bioconvergence Market is expected to grow from USD 64.2 Billion in 2024-e at a CAGR of 17.2% to touch USD 166.7 Billion by 2030. The Healthcare Bioconvergence Market is dominated by key players such as Medtronic, GE Healthcare, Philips Healthcare, IBM Watson Health, Abbott Laboratories, and Roche Diagnostics.